|
Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
|
Human and Animal Cells
|
PC-9(RCB4455)
,
II-18(RCB2093)
,
A549(RCB0098)
,
HLC-1(RCB0083)
,
Sq-1(RCB1905)
,
EBC-1(RCB1965)
,
RERF-LC-AI(RCB0444)
|
83110
|
Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells.
|
Cancer Immunol Res |
2016-12-1 |
Pubmed
Full text
|
|
Human and Animal Cells
|
Ba/F3(RCB0805)
,
WEHI-3(RCB0035)
|
67408
|
EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs.
|
Clin Cancer Res |
2015-12-1 |
Pubmed
Full text
|
|
Human and Animal Cells
|
Ba/F3
|
65869
|
Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer.
|
Mol Cancer Ther |
2017-2-1 |
Pubmed
Full text
|
|
Human and Animal Cells
|
K562
,
HeLa
,
COS-7(RCB0539)
|
45382
|
Synergistic cytotoxicity of afatinib and cetuximab against EGFR T790M involves Rab11-dependent EGFR recycling.
|
Biochem Biophys Res Commun |
2014-12-12 |
Pubmed
Full text
|
|
Human and Animal Cells
|
MRC-5
|
44834
|
Ability of the Met kinase inhibitor crizotinib and new generation EGFR inhibitors to overcome resistance to EGFR inhibitors.
|
PLoS One |
2013-1-1 |
Pubmed
Full text
|
